Showing results (281-290 of 855) with videos related to
Sort By:
Pageof 86
La Medicina Del Lavoro|October 25, 2023
No Excess Total Mortality in Italy in the First Semester of 2023 at All Ages and in the Working Age PopulationGianfranco Alicandro, Alberto Gerli, Claudia Santucci, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic reviewAnnalisa Perna, Arrigo Schieppati, Javier Zamora, et al.Advances in Experimental Medicine and Biology|March 11, 2010
Successes and disappointments with clinical islet transplantationPaolo Cravedi, Irene M van der Meer, Sara Cattaneo, et al.Kidney International|August 8, 2002
Effect of high dose ramipril with or without indomethacin on glomerular selectivityRoberto Pisoni, Piero Ruggenenti, Fabio Sangalli, et al.Journal of the American Society of Nephrology : JASN|December 3, 2011
Sodium intake, ACE inhibition, and progression to ESRDStefan Vegter, Annalisa Perna, Maarten J Postma, et al.Pediatric Nephrology (Berlin, Germany)|July 9, 2008
Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesisYun-Wen Chen, Stella Tran, Isabelle Chenier, et al.Endocrinology|July 20, 2002
High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cellsTusty-Jiuan Hsieh, Shao-Ling Zhang, Janos G Filep, et al.Pediatric Research|November 17, 2015
Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetesYessoufou Aliou, Min-Chun Liao, Xin-Ping Zhao, et al.Lancet (London, England)|May 22, 2002
Combined kidney and liver transplantation for familial haemolytic uraemic syndromeGiuseppe Remuzzi, Piero Ruggenenti, Daniela Codazzi, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H)Lorenzo Gallon, Elena Gagliardini, Ariela Benigni, et al.Pageof 86